These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 776348)

  • 1. Comparison of prothrombin complex concentrate and vitamin K1 in oral anticoagulant reversal.
    Taberner DA; Thomson JM; Poller L
    Br Med J; 1976 Jul; 2(6027):83-5. PubMed ID: 776348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding.
    Quinlan DJ; Eikelboom JW; Weitz JI
    Circulation; 2013 Sep; 128(11):1179-81. PubMed ID: 23935012
    [No Abstract]   [Full Text] [Related]  

  • 3. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial.
    Pabinger I; Brenner B; Kalina U; Knaub S; Nagy A; Ostermann H;
    J Thromb Haemost; 2008 Apr; 6(4):622-31. PubMed ID: 18208533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa.
    Barton CA; Johnson NB; Case J; Warden B; Hughes D; Zimmerman J; Roberti G; McMillian WD; Schreiber M
    Am J Emerg Med; 2015 Nov; 33(11):1562-6. PubMed ID: 26143317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose.
    Holland L; Warkentin TE; Refaai M; Crowther MA; Johnston MA; Sarode R
    Transfusion; 2009 Jun; 49(6):1171-7. PubMed ID: 19210325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Attempted suicide with super warfarin].
    Rodrigo Casanova P; Rodríguez Fernández V; García Peña JM; Aguilera Celorrio L
    Rev Esp Anestesiol Reanim; 2005 Oct; 52(8):506-7. PubMed ID: 16281750
    [No Abstract]   [Full Text] [Related]  

  • 7. Prothrombin complex concentrates as reversal agents for new oral anticoagulants: lessons from preclinical studies with Beriplex.
    Dickneite G
    Clin Lab Med; 2014 Sep; 34(3):623-35. PubMed ID: 25168947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.
    Makris M; Greaves M; Phillips WS; Kitchen S; Rosendaal FR; Preston EF
    Thromb Haemost; 1997 Mar; 77(3):477-80. PubMed ID: 9065997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study.
    Hanke AA; Joch C; Görlinger K
    Br J Anaesth; 2013 May; 110(5):764-72. PubMed ID: 23335567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate.
    Pabinger-Fasching I
    Thromb Res; 2008; 122 Suppl 2():S19-22. PubMed ID: 18549908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombin complex concentrates: clinical use.
    Menache D
    Ann N Y Acad Sci; 1981; 370():747-56. PubMed ID: 6791551
    [No Abstract]   [Full Text] [Related]  

  • 12. Prothrombin complex concentrate (Beriplex P/N).
    Scott LJ
    Drugs; 2009 Oct; 69(14):1977-84. PubMed ID: 19747012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic approaches to factor X deficiency with emphasis on the use of a new clotting-factor concentrate (Konyne).
    O'Leary DS; Ruymann FB; Conrad ME
    J Lab Clin Med; 1971 Jan; 77(1):23-32. PubMed ID: 5540427
    [No Abstract]   [Full Text] [Related]  

  • 14. ACP Journal Club. 4F-PCC was noninferior to plasma in patients with acute major bleeding who needed urgent VKA reversal.
    Lang E
    Ann Intern Med; 2014 Apr; 160(8):JC6. PubMed ID: 24733223
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of Christmas disease and Stuart-Prower deficiency with a prothrombin-complex concentrate (factors II, VII, IX, X).
    Tullis JL; Melin M
    Bibl Haematol; 1968; 29():1134-9. PubMed ID: 5700309
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of four-factor prothrombin complex concentrate in the emergency department: a review.
    Willis CM; Hall AB
    J Emerg Nurs; 2015 Jan; 41(1):9-12. PubMed ID: 25016517
    [No Abstract]   [Full Text] [Related]  

  • 17. Prothrombal: a new concentrate of human prothrombin complex for clinical use.
    Bruning PF; Loeliger EA
    Br J Haematol; 1971 Oct; 21(4):377-98. PubMed ID: 5001176
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma superwarfarin levels and vitamin K1 treatment in dogs with anticoagulant rodenticide poisoning.
    Robben JH; Kuijpers EA; Mout HC
    Vet Q; 1998 Jan; 20(1):24-7. PubMed ID: 9477532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of prothrombin complex concentrates in anticoagulation.
    van Veen SQ; Strengers PF
    Am J Hematol; 2008 Apr; 83(4):344-5. PubMed ID: 18213649
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin supplement counteracts the prohemostatic effect of prothrombin complex concentrate and factor IX concentrate: An in vitro evaluation.
    Brinkman HJ; Patiwael S; Tripathi S; Meijers JC
    Thromb Res; 2016 Mar; 139():102-10. PubMed ID: 26916304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.